Citizens of democratic societies are increasingly demanding transparency, whether in politics, public services or...
Have you ever heard of cancer thunderstorms? It is the latest concept in cancer genomics.
Time never stands still in the pharmaceutical industry and nowhere is this more true than in the reporting of...
Improving the efficacy and effectiveness of clinical monitoring is key in managing study budgets. A report published...
The days of subscription-based journals may be numbered with the news that the Wellcome Trust is putting its very...
A recent review of data on ClinicalTrials.gov (2007 - 2010) reported that clinical trials are falling short of...
For decades we have expected antibiotics to protect us from infection but the growing problem of antibiotic...
Those involved in the pharmaceutical industry for any length of time will recognise the thalidomide tragedy as one...
Smart phones and the associated technology play major roles in many of our lives. This has not gone unnoticed by the...
The double-blind, randomised, placebo controlled trial (RCT) is accepted by the pharmaceutical industry and...
Specialists in clinical pharmacology – phase 1 and early phase 2 trials
